Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Comparison of two ferritin assay platforms to assess their level of agreement in measuring serum and plasma ferritin levels in patients with chronic kidney disease

Fig. 1

Scatter plots showing the relationship between ferritin levels as measured by the Ortho-Clinical Diagnostics Vitros 7600 platform versus the Abbott ARCHITECT i1000 platform; a Top End of Australia, b Central Australia, c combined Top End and Centralia Australia. Correlation is less tight at higher ferritin levels above 500 µg/L

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us